Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial
暂无分享,去创建一个
P. Sørensen | H. Søndergaard | A. Oturai | J. Frederiksen | J. Erälinna | Xingchen Wu | F. Sellebjerg | J. Lycke | E. Stenager | C. Malmeström | A. Edland | J. Erälinna